![David Barrett](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David Barrett
Corporate Officer/Principal presso Flame Biosciences LLC
Profilo
David J.
Barrett is currently the Head-Transition at Flame Biosciences LLC.
He previously worked as a Director at Fortress Biotech, Inc. and held CFO positions at Overture Financial Services LLC, Ventrus Biosciences, Inc., Overture Asset Managers LLC, and Woodbrook Group Holdings, Inc. He was also the CFO, COO & Principal Accounting Officer at Assembly Biosciences, Inc. from 2015 to 2018.
Barrett received his undergraduate and graduate degrees from the University of Florida in 1999.
Posizioni attive di David Barrett
Società | Posizione | Inizio |
---|---|---|
Flame Biosciences LLC
![]() Flame Biosciences LLC Miscellaneous Commercial ServicesCommercial Services Flame Biosciences, Inc. operates as a biotechnology company. The firm offers research, development and commercialization of transformative therapies for cancer and other inflammatory conditions. The company was founded by Charles J. Fisher Jr., Patrick J. Scannon and Bob Stein and is headquartered in New York, NY. | Corporate Officer/Principal | 01/04/2019 |
Precedenti posizioni note di David Barrett
Società | Posizione | Fine |
---|---|---|
ASSEMBLY BIOSCIENCES, INC. | Direttore Finanziario/CFO | 08/03/2018 |
WOODBROOK GROUP HOLDINGS INC. | Direttore Finanziario/CFO | 21/07/2009 |
Overture Financial Services LLC
![]() Overture Financial Services LLC Investment ManagersFinance Overture Financial Services LLC specializes in institutional consulting services, infrastructure design, systems implementation and project management for sovereign wealth funds, central banks, social security systems, and financial institutions. The company is headquartered in New York, NY. | Direttore Finanziario/CFO | 01/04/2006 |
Overture Asset Managers LLC
![]() Overture Asset Managers LLC Investment ManagersFinance Overture Asset Managers LLC acquires boutique money managers and provides investment management services. The private company is based in New York, NY. | Direttore Finanziario/CFO | 01/01/2005 |
Deloitte & Touche LLP
![]() Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/09/2003 |
Formazione di David Barrett
University of Florida | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 3 |
---|---|
WOODBROOK GROUP HOLDINGS INC. | Finance |
FORTRESS BIOTECH, INC. | Health Technology |
ASSEMBLY BIOSCIENCES, INC. | Health Technology |
Aziende private | 5 |
---|---|
Overture Financial Services LLC
![]() Overture Financial Services LLC Investment ManagersFinance Overture Financial Services LLC specializes in institutional consulting services, infrastructure design, systems implementation and project management for sovereign wealth funds, central banks, social security systems, and financial institutions. The company is headquartered in New York, NY. | Finance |
Overture Asset Managers LLC
![]() Overture Asset Managers LLC Investment ManagersFinance Overture Asset Managers LLC acquires boutique money managers and provides investment management services. The private company is based in New York, NY. | Finance |
Ventrus Biosciences, Inc.
![]() Ventrus Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ventrus Biosciences, Inc. is a development stage specialty pharmaceutical company engages in development of late-stage prescription drugs for gastrointestinal disorders, specifically hemorrhoidal disease, anal fissures, and fecal incontinence. Its major pharmaceutical progress made in the gastrointestinal therapeutic areas of gastroesophageal reflux, peptic ulcer disease, and inflammatory bowel disease. Ventrus Biosciences products includes VEN 307 (topical diltiazem), is intended to treat pain associated with anal fissures and VEN 308 (topical phenylephrine), is intended to treat fecal incontinence. The company was founded on October 10, 2005 and is headquartered in New York, NY. | Health Technology |
Deloitte & Touche LLP
![]() Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Commercial Services |
Flame Biosciences LLC
![]() Flame Biosciences LLC Miscellaneous Commercial ServicesCommercial Services Flame Biosciences, Inc. operates as a biotechnology company. The firm offers research, development and commercialization of transformative therapies for cancer and other inflammatory conditions. The company was founded by Charles J. Fisher Jr., Patrick J. Scannon and Bob Stein and is headquartered in New York, NY. | Commercial Services |
- Borsa valori
- Insiders
- David Barrett